Healthcare Industry News

 One of the main factors propelling the demand for medication management services is the rising adoption of mobile health (mHealth) technologies throughout the world. Since the last few years, there has been a massive rise in the demand for mHealth technologies, on account of the increasing internet penetration and surging number of smartphone users. Moreover, the mHealth technologies are cost-effective and provide effective remote patient monitoring solutions, owing to which they are being increasingly adopted across the world.  The other major factors boosting the demand for medication management services are the rising geriatric population, increasing healthcare expenditure, rising incidence of chronic diseases, increasing adoption of remote patient monitoring services, and the mushrooming number of initiatives being taken by the governments as well as the various private and public organizations of several countries in this niche. As a result, the global medication management mark

 “Cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018.”, says the World Health Organization (WHO). This common yet deadly disease involves the growth of cells faster than the older ones die. The increasing mass of cells takes the form of tumors, which have the tendency to rapidly spread to other parts of the body (metastasis) and severely harm them. Among the various causes of cancer are alcohol and tobacco consumption, environmental pollution, certain pre-existing diseases, such as infections, and genetic predisposition. P&S Intelligence credits the rising cancer incidence around the world while forecasting that the radiotherapy market will grow from $7,222.4 million in 2019 to $17,194.4 million in 2030 , at an 8.4% CAGR between 2020 and 2030. Commonly called radiation treatment, radiotherapy involves the usage of high-energy radiation to shrink or destroy cancer cells. Apart from surgery, chemotherapy

 The Latin American (LATAM) fracture management market will progress at a CAGR of 5.1% during the forecast period (2020–2030), on account of the surging prevalence of osteoporosis, burgeoning aging population, increasing incidence of road crashes, and soaring number of knee and hip replacement surgeries, in the region. Additionally, the mounting healthcare expenditure and escalating awareness about fracture management products will also aid the market size to grow from $592.0 million in 2019 to $1,002.9 million by 2030. The rising prevalence of osteoporosis will augment the demand for fracture management products in LATAM in coming years, as this bone disease leads to the loss of bone density. According to the International Osteoporosis Foundation (IOF), 655,648 cases of hip fractures will be recorded by 2050. Furthermore, the foundation states that 2.62 million women will be diagnosed with osteoporosis in Argentina by 2050. Also, the IOF estimates that 1 in 3 patients with hip fractu